Search research articles
Contact Us
Filters
Showing results (41-50 of 142) with videos related to
Page
of 15
Sort By:
American Journal of Hematology
|
January 13, 2012
Guidelines for pediatric management of severe chronic neutropenia
David C Dale, Laurence A Boxer
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 9, 2011
Long-term outcomes of myeloid growth factor treatment
Gary H Lyman, David C Dale
Seminars in Hematology
|
July 11, 2006
Severe congenital neutropenia
Karl Welte, Cornelia Zeidler, David C Dale
The Journal of Infectious Diseases
|
May 7, 2002
Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma
Kai Hübel, David C Dale, W Conrad Liles
Expert Review of Hematology
|
November 18, 2023
The promise of novel treatments for severe chronic neutropenia
David C Dale, Audrey Anna Bolyard, Vahagn Makaryan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2003
Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices
Gary H Lyman, David C Dale, Jeffrey Crawford
Cancer
|
January 13, 2004
Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management
Jeffrey Crawford, David C Dale, Gary H Lyman
The New England Journal of Medicine
|
September 17, 2010
Preparing for a consumer-driven genomic age
James P Evans, David C Dale, Cathy Fomous
Seminars in Hematology
|
April 17, 2002
Cyclic neutropenia
David C Dale, Audrey Anna Bolyard, Andrew Aprikyan
Blood
|
August 8, 2008
The phagocytes: neutrophils and monocytes
David C Dale, Laurence Boxer, W Conrad Liles
Page
of 15
Search research articles
Search
Showing results (41-50 of 142) with videos related to
Sort By:
Page
of 15
American Journal of Hematology
|
January 13, 2012
Guidelines for pediatric management of severe chronic neutropenia
David C Dale, Laurence A Boxer
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 9, 2011
Long-term outcomes of myeloid growth factor treatment
Gary H Lyman, David C Dale
Seminars in Hematology
|
July 11, 2006
Severe congenital neutropenia
Karl Welte, Cornelia Zeidler, David C Dale
The Journal of Infectious Diseases
|
May 7, 2002
Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma
Kai Hübel, David C Dale, W Conrad Liles
Expert Review of Hematology
|
November 18, 2023
The promise of novel treatments for severe chronic neutropenia
David C Dale, Audrey Anna Bolyard, Vahagn Makaryan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2003
Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices
Gary H Lyman, David C Dale, Jeffrey Crawford
Cancer
|
January 13, 2004
Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management
Jeffrey Crawford, David C Dale, Gary H Lyman
The New England Journal of Medicine
|
September 17, 2010
Preparing for a consumer-driven genomic age
James P Evans, David C Dale, Cathy Fomous
Seminars in Hematology
|
April 17, 2002
Cyclic neutropenia
David C Dale, Audrey Anna Bolyard, Andrew Aprikyan
Blood
|
August 8, 2008
The phagocytes: neutrophils and monocytes
David C Dale, Laurence Boxer, W Conrad Liles
Page
of 15